Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie N Dorman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scientific Reports|November 15, 2014
Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancerStephanie N Dorman, Coby Viner, Peter K Rogan
F1000Research|April 22, 2014
Validation of predicted mRNA splicing mutations using high-throughput transcriptome dataCoby Viner, Stephanie N Dorman, Ben C Shirley, et al.
Nucleic Acids Research|February 5, 2013
Expanding probe repertoire and improving reproducibility in human genomic hybridizationStephanie N Dorman, Ben C Shirley, Joan H M Knoll, et al.
Molecular Oncology|September 16, 2015
Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learningStephanie N Dorman, Katherina Baranova, Joan H M Knoll, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scientific Reports|November 15, 2014
Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancerStephanie N Dorman, Coby Viner, Peter K Rogan
F1000Research|April 22, 2014
Validation of predicted mRNA splicing mutations using high-throughput transcriptome dataCoby Viner, Stephanie N Dorman, Ben C Shirley, et al.
Nucleic Acids Research|February 5, 2013
Expanding probe repertoire and improving reproducibility in human genomic hybridizationStephanie N Dorman, Ben C Shirley, Joan H M Knoll, et al.
Molecular Oncology|September 16, 2015
Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learningStephanie N Dorman, Katherina Baranova, Joan H M Knoll, et al.
Pageof 1